Citigroup »

Actuate Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Actuate Therapeutics shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-09-30 $82k 11k 7.45